War has affected every aspect of life in Israel, but its biopharma leaders are determined to work through the adversity. They view their ability to continue to operate in the midst of war as evidence of the country’s resilience, a symbol of defiance, and a way to remind the world of the outsized role Israel plays in the global life sciences ecosystem. Read...
Read MoreThe intensifying Israel-Gaza war prompted by widespread attacks by Hamas has prompted a new wave of cyberattacks across the region. Read more...
Read MoreOne in four social media users posting about the ongoing conflict between Hamas and Israel is a fake account. This is the claim made by Cyabra, an Israeli social media threat intelligence company – and the vast amount of data scraped, compiled, and analyzed by the company’s platform backs it up. Read more...
Read MoreSAN FRANCISCO, Oct. 12, 2023 /PRNewswire/ — People.ai today announced the launch of SalesAI, a fully integrated generative AI sales solution that will revolutionize the way company leaders approach revenue, team structure and coaching, and go-to-market execution. SalesAI automates manual workflows and day-to-day tasks, prepares salespeople for customer meetings, speeds up pipeline creation, uncovers hidden truths about deals, and enables prescriptive coaching recommendations. Read more...
Read MoreSAN FRANCISCO, Oct. 12, 2023 /PRNewswire/ — MasterClass, the streaming platform where anyone can learn from the world’s best, today announced that Whitney Wolfe Herd, founder and CEO of Bumble Inc. and youngest self-made woman billionaire, will teach a class on how to rewrite the rules and move ahead—in life and work. Wolfe Herd will give members an inside look into her journey of launching the women-first dating and social networking app Bumble, and share advice on how to follow your ambition with confidence, build a viral brand and redefine success. The class is available now exclusively on MasterClass, where subscribers have unlimited access to all 185+ instructors with an annual membership. Read More...
Read More
